Healthcare -
Biotechnology - NASDAQ - US
$ 1.09
-0.909 %
$ 227 M
Market Cap
-1.54
P/E
SGMO - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities SGMO - Sangamo Therapeutics, Inc.
154 M
LAST VALUE
-21.35%
2 YEAR CAGR
23.41%
5 YEAR CAGR
15.58%
10 YEAR CAGR